VPS13B: A Potential Drug Target for A Rare Neurological Disease

Target Name: VPS13B

NCBI ID: G157680

VPS13B

VPS13B: A Potential Drug Target for A Rare Neurological Disease

VPS13B (Versick-Paoli syndrome 1) is a rare autosomal recessive disorder that is characterized by progressive cognitive decline, behavioral changes, and collapse arthropathy. At present, although there have been some studies to provide in-depth understanding of VPS13B, the disease is still considered a difficult to treat neurological disease. However, recent research suggests that VPS13B may be a potential drug target or biomarker, which brings new hope for treating the disease.

VPS13B is a disease caused by genetic mutations that cause abnormal proteins to appear in the cytoplasm of neurons. These abnormal proteins interfere with the normal function of neurons, leading to neuronal damage and death. The pathophysiological mechanism of VPS13B has not been fully understood, but studies have shown that the disease is closely related to neuronal damage and apoptosis.

Although the etiology and pathogenesis of VPS13B are not fully understood, treatment of the disease remains challenging. Currently, the treatment for VPS13B is mainly supportive care, including providing patients with adequate nutrition and fluids to maintain their fluid balance, and giving patients appropriate medications to relieve their symptoms.

However, recent studies suggest that VPS13B may be a potential drug target or biomarker. The researchers found that abnormal proteins of VPS13B persisted after neuronal death, suggesting that these proteins may play an important role in the development of the disease. In addition, some studies have also found that abnormal proteins of VPS13B are related to neuronal damage and apoptosis. These findings bring new ideas for treating VPS13B.

Currently, researchers are exploring the potential of VPS13B as a drug target or biomarker. Some researchers are studying how to use drugs to inhibit the abnormal protein of VPS13B to slow neuronal damage and death. Other researchers are studying how the abnormal protein of VPS13B can be used as a diagnostic or prognostic marker to help predict disease progression and treatment response.

In addition, some researchers have also found that abnormal proteins in VPS13B may be related to some neurodegenerative diseases. For example, some researchers have found that the abnormal protein of VPS13B is associated with Alzheimer's disease, which has brought new hope for treating the disease.

In summary, VPS13B is a rare neurological disease for which there is currently no effective treatment. However, recent studies suggest that VPS13B may be a potential drug target or biomarker. Researchers are exploring the potential of VPS13B as a drug target or biomarker to bring new hope for treating this disease.

Protein Name: Vacuolar Protein Sorting 13 Homolog B

Functions: Mediates the transfer of lipids between membranes at organelle contact sites (By similarity). Binds phosphatidylinositol 3-phosphate (By similarity). Functions as a tethering factor in the slow endocytic recycling pathway, to assist traffic between early and recycling endosomes (PubMed:30962439, PubMed:24334764, PubMed:32375900). Involved in the transport of proacrosomal vesicles to the nuclear dense lamina (NDL) during spermatid development (By similarity). Plays a role in the assembly of the Golgi apparatus, possibly by mediating trafficking to the Golgi membrane (PubMed:21865173). Plays a role in the development of the nervous system, and may be required for neuron projection development (PubMed:25492866, PubMed:32560273). May also play a role during adipose tissue development (PubMed:26358774). Required for maintenance of the ocular lens (By similarity)

The "VPS13B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VPS13B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets